ArticleCell and tissue banking2026
Development of biomimetic mouldable osseous scaffold engineered from bioactive decellularized extracellular matrix-polymer-gel composite: a potential bone substitute.
Article in Cell and tissue banking, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Critical-sized bone defects remain a major clinical challenge in veterinary orthopaedics due to limited intrinsic regenerative capacity and the drawbacks of conventional grafting options. This study reports the development and systematic evaluation of a novel bioinspired osseous scaffold engineered from decellularized bubaline cancellous bone granules, collagen gel, and polycaprolactone, with optional enrichment using autologous adipose-derived stromal vascular fraction. Scaffold physicochemical characteristics-including porosity, material density, and ultrastructure-were assessed through liquid displacement assays, histomorphometry, and scanning electron microscopy, confirming complete decellularization, interconnected porosity, and favourable matrix architecture. Mechanical testing demonstrated significantly enhanced tensile strength in the composite scaffold compared with plain acellular bone-collagen constructs. In vitro biocompatibility was validated by adipose derived mesenchymal stem cell adhesion, proliferation, and migration, with DAPI staining confirming uniform cellular distribution and robust scaffold-cell interactions, along with Alizarin Red S Staining for assessment of osteogenic mineralization.
Indexed as
Identifiers
42573640What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.